Several factors are associated with increased mortality in patients with bullous pemphigoid, with mortality rates increasing 5 years after diagnosis.

Recent studies highlight the potential pathophysiology and presentation of immune checkpoint inhibitor–associated cutaneous ...

Bullous pemphigoid (BP) is a well-known condition triggered by autoantibodies directed against hemidesmosomal proteins involved in the adhesion of basal keratinocytes to the basement membrane.

Dupilumab use among adults with bullous pemphigoid was associated with significant improvements in several efficacy measures, with no new safety signals identified. Dupilumab offers significant ...

The risk of some skin cancers, including squamous cell carcinoma, basal cell carcinoma, and non-melanoma skin cancer, was particularly heightened among patients with severe mucous membrane pemphigoid.

About two-thirds of adults reported experiencing no sunburns in the past 12 months, while 2.1 percent reported experiencing more than six. HealthDay News — About two-thirds of U.S. adults report ...

New data comparing abelacimab (MAA868) with rivaroxaban (Xarelto) in patients with atrial fibrillation were presented at the American College of Cardiology 2025 Annual Scientific Session. The ...